by Robert Hayes Posted on April 10, 2019April 10, 2019 BUSINESS BRIEF: Wilmington’s Charles River Labs & CHDI Foundation Extend Huntington’s Disease Collaboration Read More
by Robert Hayes Posted on February 16, 2019February 16, 2019 BUSINESS BRIEF: Wilmington’s Charles River Labs Signs Binding Offer to Acquire Citoxlab Read More
by Robert Hayes Posted on January 17, 2019January 17, 2019 BUSINESS BRIEF: Wilmington’s Charles River Labs Recognized For Advancing Gender Diversity In The Workplace Read More
by Robert Hayes Posted on January 11, 2019January 11, 2019 BUSINESS BRIEF: Wilmington’s Charles River Labs & Atomwise Form Strategic Alliance Read More
by Robert Hayes Posted on October 26, 2018October 26, 2018 BUSINESS BRIEF: Wilmington’s Charles River Labs Enter Exclusive Partnership With Distributed Bio, Inc. Read More
by Robert Hayes Posted on October 16, 2018October 16, 2018 Wilmington’s Charles River Labs Awarded $95.7 Million Contract By National Institute Of Allergy & Infectious Diseases Read More
by Robert Hayes Posted on May 6, 2018May 7, 2018 Wilmington’s Charles River Labs Announces Extended Relationship With Michael J. Fox Foundation Read More
by Robert Hayes Posted on March 10, 2018March 10, 2018 Wilmington’s Charles River Labs Makes Expansions to Global Biologics Infrastructure Read More
by Robert Hayes Posted on February 13, 2018February 13, 2018 Wilmington’s Charles River Laboratories To Acquire MPI Research Read More
by Robert Hayes Posted on September 18, 2017September 18, 2017 Wilmington’s Charles Rivers Announces Recipients Of 1st Annual ‘Research Models in Drug Discovery’ Award Read More
by Robert Hayes Posted on September 3, 2017September 4, 2017 Wilmington’s Charles River Labs To Hold World Congress On Animal Models In Drug Discovery & Development Read More
by Robert Hayes Posted on August 7, 2017August 7, 2017 Wilmington’s Charles River Laboratories Acquires ‘Brains On-Line’ Read More
You must be logged in to post a comment.